At a glance
- Originator Mediolanum
- Class Antibacterials; Quinolones
- Mechanism of Action DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Helicobacter infections
Most Recent Events
- 06 Dec 2001 Discontinued-Preclinical for Helicobacter infections in Italy (Unknown route)
- 08 Jun 2001 No-Development-Reported for Helicobacter infections in Italy (Unknown route)
- 19 May 1998 Preclinical development for Helicobacter infections in Italy (Unknown route)